The cost effectiveness of tube feeding versus oral nutritional supplements in hospitalized patients with IBD

Completed

• Conditions: Bowel Disease; Inflammatory Bowel Disease; 10017977

• Registration Number: NL-OMON33890
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 60

Inclusion Criteria

· Endoscopically or histologically proven Crohn*s disease or ulcerative
colitis before 3 months prior to randomization
· Age 18-70 years
· Written informed consent
· Adequate contraception for males and females during treatment and
follow up (written confirmation)
· All therapy is permitted concomitant therapy
· Patients must be hospitalized

Exclusion Criteria

· Pregnancy, breast-feeding
· Any other condition which in the opinion of the investigator would make
the patient unsuitable for enrollment, or could interfere with the patient
participating in and completing the study
· Total parental nutrition
· Bowel perforation
· Short bowel
· Neoplastic condition of the subject

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The reduction of hospital stay in days of 30%</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Quality of life and psychopathology by psychological assessment using the IBDQ<br /><br>questionnaire</p><br>